Skip to main content
Figure 7 | BMC Cancer

Figure 7

From: Altered efficacy of AT1R-targeted treatment after spontaneous cancer cell-AT1R upregulation

Figure 7

CD34 staining (measured as the length of CD34-positive endothelium per tumour area) from irbesartan sensitive (IRB-sensitive; AT1R LOW ) and insensitive (IRB-insensitive; AT1R HI ) tumours either treated with irbesartan (IRB) or untreated. n = 5 or 6 for each group except for AT1RLOW tumours which, because of the reduced tumour load, had additional samples (n of 10). Between 10 and 30 images were taken from each mouse across 1 to 5 tumours (dependent on tumour load). Representative images are shown below. Representative images are shown to the right. Significant P values between 0.01 and 0.05 are shown with an *, those less than 0.01 are shown with **. Data are presented as mean ± S.E.M.

Back to article page